Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 22:S1535-6108(25)00553-7.
doi: 10.1016/j.ccell.2025.12.019. Online ahead of print.

IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma

Affiliations

IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma

Triantafyllia Karakousi et al. Cancer Cell. .

Abstract

Lymphatic vessels activate anti-tumor immune surveillance and support metastasis. Whether there are distinct lymphatic phenotypes that govern immunity and metastasis remains unclear. Here we reveal that cytotoxic immunity normalizes lymphatic function and uncouples immune and metastatic potential. We demonstrate that intratumoral lymphatic vessel density negatively correlates with cytotoxic immunity and that IFNγ reprograms the intratumoral lymphatic state. Lymphatic deletion of Ifngr1 expanded the intratumoral lymphatic network and drove the emergence of a tip-like state that promotes lymph node metastasis but not dendritic cell migration or response to immune checkpoint blockade (ICB). Mechanistically, IFNγ restrains proliferation and cell state programs through inhibition of mitochondrial respiration. Lymphatic-specific inhibition of mitochondrial complex III restrained the intratumoral tip-like state, blocked metastasis, and enhanced the response to ICB. Our data reveal that IFNγ induces a metabolic and phenotypic switch in tumor-associated lymphatic vessels that blocks regional metastasis and reinforces immune surveillance.

Keywords: immune checkpoint blockade; immune surveillance; interferon gamma; lymph node; lymphangiogenesis; lymphatic vessels; melanoma; metabolism; metastasis; oxidative phosphorylation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no conflicts of interest.

Update of

References

    1. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, et al. (2014). Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma. N. Engl. J. Med 370, 599–609. 10.1056/NEJMoa1310460. - DOI - PMC - PubMed
    1. Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, and Shah M (2017). Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update. J. Breast Cancer 20, 217. 10.4048/jbc.2017.20.3.217. - DOI - PMC - PubMed
    1. Giorgadze TA, Zhang PJ, Pasha T, Coogan PS, Acs G, Elder DE, and Xu X (2004). Lymphatic vessel density is significantly increased in melanoma. J. Cutan. Pathol 31, 672–677. 10.1111/j.0303-6987.2004.00249.x. - DOI - PubMed
    1. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, et al. (2002). Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296, 1883–1886. 10.1126/science.1071420. - DOI - PubMed
    1. Gengenbacher N, Singhal M, Mogler C, Hai L, Milde L, Pari AAA, Besemfelder E, Fricke C, Baumann D, Gehrs S, et al. (2021). Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis. Cancer Discov 11, 424–445. 10.1158/2159-8290.CD-20-0122. - DOI - PubMed

LinkOut - more resources